Pine Bridge Investments, L.P. Biogen Inc. Transaction History

Pine Bridge Investments, L.P.

$13.1 Billion
Q3 2024

A detailed history of Pine Bridge Investments, L.P. transactions in Biogen Inc. stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 47,084 shares of BIIB stock, worth $7.02 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

47,084

Previous 11,260 318.15%

Holding current value

$7.02 Million

Previous $2.61 Million 249.66%

% of portfolio

0.07%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $6.77 Million - $8.48 Million	35,824 Added 318.15%	47,084 $9.13 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $978,701 - $1.22 Million	-5,137 Reduced 31.33%	11,260 $2.61 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $785,958 - $992,400	-3,707 Reduced 18.44%	16,397 $3.54 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $1.52 Million - $1.83 Million	6,838 Added 51.55%	20,104 $5.2 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.43 Million - $1.62 Million	5,654 Added 74.28%	13,266 $3.41 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $1.08 Million - $1.25 Million	3,918 Added 106.06%	7,612 $2.17 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $871,277 - $992,786	3,396 Added 1139.6%	3,694 $1.03 Million
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $75,227 - $91,402	298 New	298 $82,000
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $34,319 - $40,812	-183 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $1.61 Million - $2.03 Million	-8,304 Reduced 97.84%	183 $39,000
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $98,972 - $127,194	442 Added 5.49%	8,487 $2.04 Million
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $2.28 Million - $2.97 Million	8,045 New	8,045 $2.28 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $6,216 - $9,953	-24 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $7.38 Million - $8.65 Million	-30,390 Reduced 99.92%	24 $7,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $329,818 - $496,459	-1,396 Reduced 4.39%	30,414 $7.45 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $2.44 Million - $2.81 Million	-9,205 Reduced 22.44%	31,810 $9.02 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $2.12 Million - $2.8 Million	-8,184 Reduced 16.63%	41,015 $11 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $79,848 - $101,288	-297 Reduced 0.6%	49,199 $15.6 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $88,024 - $121,628	-400 Reduced 0.8%	49,496 $14.7 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $2.06 Million - $2.31 Million	-9,463 Reduced 15.94%	49,896 $11.6 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $7.82 Million - $8.62 Million	-35,672 Reduced 37.54%	59,359 $13.9 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $2.33 Million - $3.65 Million	10,771 Added 12.78%	95,031 $22.5 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $6.24 Million - $7.91 Million	22,417 Added 36.25%	84,260 $25.4 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.54 Million - $2.01 Million	5,246 Added 9.27%	61,843 $21.9 Million
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $12.9 Million - $15.3 Million	49,989 Added 756.49%	56,597 $16.4 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $307,733 - $435,237	1,183 Added 21.81%	6,608 $1.81 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $631,584 - $707,422	2,053 Added 60.88%	5,425 $1.73 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $840,919 - $986,102	2,991 Added 785.04%	3,372 $1.06 Million
Q2 2017 Aug 11, 2017	BUY	N/A	381	381 $103,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.

Account

Pine Bridge Investments, L.P. Biogen Inc. Transaction History